美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immune Design

5.85

0.0000

成交量：- -

成交额：- -

市值：2.83亿

市盈率：-5.14

高：5.85

开：5.85

低：5.85

收：5.85

52周最高：5.85

52周最低：1.10

股本：4,836.52万

流通股本：3,047.57万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.1373

每股收益(LYR):-1.1373

净资产收益率：--

总资产收益率：--

市净率：3.08

市盈率(LYR):-5.14

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Immune Design

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.immunedesign.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Immune Design Corp.于2008年2月在特拉华州成立。公司是一家与新一代的体内设计疗法使人体的免疫系统足够抵抗疾病。公司已经设计了技术来激活创建肿瘤特异性细胞毒性T细胞来对抗癌症的免疫系统的天然能力。公司从其发现的两个平台DCVexTM and GLAASTM中开发了多个候选产品，这些产品是公司认为其有治疗广泛患者的潜力。公司的候选产品lv305，cmb305与G100能够利用多种免疫治疗方法解决现有的治疗方法的缺点。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMDZ/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMDZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDZ\",,,,,undefined,":{"symbol":"IMDZ","market":"US","secType":"STK","nameCN":"Immune Design","latestPrice":5.85,"timestamp":1557432000000,"preClose":5.85,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":30475702,"shares":48365248,"eps":-1.13735,"marketStatus":"停牌","change":0,"latestTime":"02-23 10:26:23 EST","open":5.85,"high":5.85,"low":5.85,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.13735,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771880400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1406174400000,"exchange":"NASDAQ","adjPreClose":5.85,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDZ\",,,,,undefined,":{"symbol":"IMDZ","floatShares":30475702,"roa":"--","roe":"--","lyrEps":-1.13735,"shares":48365248,"dividePrice":0,"high":5.85,"amplitude":0,"preClose":5.85,"low":5.85,"week52Low":1.1,"pbRate":"3.08","week52High":5.85,"institutionHeld":0,"latestPrice":5.85,"eps":-1.13735,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.13735,"open":5.85,"prevYearClose":5.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMDZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-06","symbol":"IMDZ","fiscalQuarterEnding":"2018/09","expectedEps":-0.32,"name":null,"time":"盘后","type":"earning","dateTimestamp":1541480400000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2018-08-01","symbol":"IMDZ","fiscalQuarterEnding":"2018/06","expectedEps":-0.3,"name":null,"time":"","type":"earning","dateTimestamp":1533096000000,"reportTimeType":"","actualEps":-0.29},{"market":"US","date":"2018-05-02","symbol":"IMDZ","fiscalQuarterEnding":"2018/03","expectedEps":-0.29,"name":null,"time":"盘后","type":"earning","dateTimestamp":1525233600000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2018-03-14","symbol":"IMDZ","fiscalQuarterEnding":"2017/12","expectedEps":-0.39,"name":null,"time":"盘后","type":"earning","dateTimestamp":1521000000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2017-11-01","symbol":"IMDZ","fiscalQuarterEnding":"2017/09","expectedEps":-0.63,"name":null,"time":"盘后","type":"earning","dateTimestamp":1509508800000,"reportTimeType":"post","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMDZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMDZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.immunedesign.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immune Design Corp.于2008年2月在特拉华州成立。公司是一家与新一代的体内设计疗法使人体的免疫系统足够抵抗疾病。公司已经设计了技术来激活创建肿瘤特异性细胞毒性T细胞来对抗癌症的免疫系统的天然能力。公司从其发现的两个平台DCVexTM and GLAASTM中开发了多个候选产品，这些产品是公司认为其有治疗广泛患者的潜力。公司的候选产品lv305，cmb305与G100能够利用多种免疫治疗方法解决现有的治疗方法的缺点。","exchange":"NASDAQ","name":"Immune Design","nameEN":"Immune Design"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMDZ\",market:\"US\",,,undefined,":null}}